State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China.
ACS Synth Biol. 2021 May 21;10(5):1087-1094. doi: 10.1021/acssynbio.0c00606. Epub 2021 Apr 21.
Baicalein and scutellarein are bioactive flavonoids isolated from the traditional Chinese medicine ; however, there is a lack of effective strategies for producing baicalein and scutellarein. In this study, we developed a sequential self-assembly enzyme reactor involving two enzymes in the baicalein pathway with a pair of protein-peptide interactions in . These domains enabled us to optimize the stoichiometry of two baicalein biosynthetic enzymes recruited to be an enzymes complex. This strategy reduces the accumulation of intermediates and removes the pathway bottleneck. With this strategy, we successfully promoted the titer of baicalein by 6.6-fold (from 21.6 to 143.5 mg/L) and that of scutellarein by 1.4-fold (from 84.3 to 120.4 mg/L) in a flask fermentation, respectively. Furthermore, we first achieved the biosynthesis of baicalein directly from glucose, and the strain was capable of producing 214.1 mg/L baicalein by fed-batch fermentation. This work provides novel insights for future optimization and large-scale fermentation of baicalein and scutellarein.
黄芩素和野黄芩苷是从传统中药中分离得到的生物活性黄酮类化合物;然而,缺乏生产黄芩素和野黄芩苷的有效策略。在这项研究中,我们开发了一种涉及黄芩素途径中的两种酶的顺序自组装酶反应器,其中包含一对蛋白质 - 肽相互作用。这些结构域使我们能够优化被招募为酶复合物的两种黄芩素生物合成酶的化学计量比。该策略减少了中间体的积累并消除了途径瓶颈。通过这种策略,我们分别成功地将黄芩素的产量提高了 6.6 倍(从 21.6 到 143.5mg/L),野黄芩苷的产量提高了 1.4 倍(从 84.3 到 120.4mg/L)。此外,我们首次实现了直接从葡萄糖生物合成黄芩素,该菌株通过分批补料发酵能够生产 214.1mg/L 的黄芩素。这项工作为未来黄芩素和野黄芩苷的优化和大规模发酵提供了新的见解。